Bristol-Myers Squibb Company (BMY)
 NYSE: BMY · Real-Time Price · USD
 45.62
 +3.02 (7.09%)
  At close: Oct 30, 2025, 4:00 PM EDT
45.42
 -0.20 (-0.44%)
  After-hours: Oct 30, 2025, 7:59 PM EDT
BMY Market Cap
BMY has a market cap or net worth of $92.86 billion as of October 30, 2025. Its market cap has decreased by -13.19% in one year.
Market Cap 
 92.86B
Enterprise Value 
 129.90B
1-Year Change 
 -13.19%
Ranking 
 Category 
 Stock Price 
$45.62
Market Cap Chart
Since December 1, 1998, BMY's market cap has decreased from $124.14B to $92.86B, a decrease of -25.20%. That is a compound annual growth rate of -1.07%.
Market Cap History
| Date | Market Cap | % Change | 
|---|---|---|
| Oct 30, 2025 | 92.87B | -19.04% | 
| Dec 31, 2024 | 114.71B | 9.88% | 
| Dec 29, 2023 | 104.40B | -31.75% | 
| Dec 30, 2022 | 152.98B | 10.54% | 
| Dec 31, 2021 | 138.39B | -1.27% | 
| Dec 31, 2020 | 140.17B | 34.03% | 
| Dec 31, 2019 | 104.58B | 23.27% | 
| Dec 31, 2018 | 84.84B | -15.41% | 
| Dec 29, 2017 | 100.30B | 2.69% | 
| Dec 30, 2016 | 97.67B | -14.90% | 
| Dec 31, 2015 | 114.76B | 17.20% | 
| Dec 31, 2014 | 97.92B | 11.89% | 
| Dec 31, 2013 | 87.51B | 62.68% | 
| Dec 31, 2012 | 53.80B | -9.91% | 
| Dec 30, 2011 | 59.72B | 31.75% | 
| Dec 31, 2010 | 45.33B | -9.38% | 
| Dec 31, 2009 | 50.02B | 8.68% | 
| Dec 31, 2008 | 46.03B | -12.28% | 
| Dec 31, 2007 | 52.47B | 1.36% | 
| Dec 29, 2006 | 51.76B | 15.13% | 
| Dec 30, 2005 | 44.96B | -9.80% | 
| Dec 31, 2004 | 49.85B | -10.13% | 
| Dec 31, 2003 | 55.46B | 23.69% | 
| Dec 31, 2002 | 44.84B | -54.56% | 
| Dec 31, 2001 | 98.68B | -31.75% | 
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
 Full DefinitionRelated Stocks
| Company | Market Cap | 
|---|---|
| Eli Lilly and Company | 758.14B | 
| Johnson & Johnson | 455.48B | 
| AbbVie | 403.13B | 
| UnitedHealth Group | 312.23B | 
| AstraZeneca | 255.76B | 
| Novartis AG | 236.67B | 
| Novo Nordisk | 222.08B | 
| Abbott Laboratories | 216.98B |